Status:
COMPLETED
Myocardial Infarction Rates Overview During COVID-19 Pandemic In France: MODIF Study
Lead Sponsor:
French Cardiology Society
Collaborating Sponsors:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Myocardial Infarction
Eligibility:
All Genders
18+ years
Brief Summary
In late December 2019, an emerging disease due to a novel coronavirus (named SARS-CoV-2) rapidly spread in China and outside. France is currently facing the COVID-19 wave with more than 131 863 confir...
Detailed Description
The aim of this study is to investigate the rates and characteristics of patients presenting with acute myocardial infarction between march 1, 2020 to May 31, 2020 and compared those data with those o...
Eligibility Criteria
Inclusion
- Patients admitted on coronary angiography room for acute coronary syndrome with ST segment elevation defined by the following criteria:
- Symptoms suggestive of myocardial ischemia (ex: persistent chest pain) AND
- An elevation of the ST segment (measured from point J) visible on at least two contiguous leads with an elevation ≥ 2.5 millimeters in men \<40 years, or ≥ 2 millimeters in men ≥ 40 years, or ≥ 1.5 millimeters in women in V2-V3 leads and / or ≥ 1 millimeter in other leads (in the absence of branch block).
Exclusion
- \- 121/5000
- Contraindication to invasive management related to the general condition of the patient.
- Minors
- Pregnant women
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2020
Estimated Enrollment :
6332 Patients enrolled
Trial Details
Trial ID
NCT04357314
Start Date
March 1 2020
End Date
May 31 2020
Last Update
August 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Universitaire Carémeau
Nîmes, France, 30029